Xinghui Si

1.4k total citations
37 papers, 1.2k citations indexed

About

Xinghui Si is a scholar working on Immunology, Biomedical Engineering and Oncology. According to data from OpenAlex, Xinghui Si has authored 37 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 17 papers in Biomedical Engineering and 15 papers in Oncology. Recurrent topics in Xinghui Si's work include Immunotherapy and Immune Responses (14 papers), Nanoplatforms for cancer theranostics (13 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Xinghui Si is often cited by papers focused on Immunotherapy and Immune Responses (14 papers), Nanoplatforms for cancer theranostics (13 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Xinghui Si collaborates with scholars based in China, United States and Australia. Xinghui Si's co-authors include Wantong Song, Sheng Ma, Zhaohui Tang, Xuesi Chen, Yudi Xu, Yu Zhang, Jiayu Zhao, Zichao Huang, Shixian Lv and Guofeng Ji and has published in prestigious journals such as Advanced Materials, Nano Letters and ACS Nano.

In The Last Decade

Xinghui Si

35 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinghui Si China 19 622 470 386 346 259 37 1.2k
Yudi Xu China 15 583 0.9× 513 1.1× 380 1.0× 291 0.8× 217 0.8× 35 1.1k
Jinxing Xia China 14 500 0.8× 315 0.7× 415 1.1× 322 0.9× 290 1.1× 28 1.1k
Suxin Li China 15 435 0.7× 534 1.1× 619 1.6× 284 0.8× 237 0.9× 42 1.4k
Cao Dai Phung South Korea 20 509 0.8× 350 0.7× 407 1.1× 296 0.9× 191 0.7× 33 1.0k
Kyle C. Roche United States 14 828 1.3× 556 1.2× 550 1.4× 410 1.2× 540 2.1× 20 1.6k
Qingle Song China 15 910 1.5× 532 1.1× 579 1.5× 486 1.4× 243 0.9× 26 1.4k
Edikan Archibong United States 9 577 0.9× 279 0.6× 394 1.0× 225 0.7× 207 0.8× 17 1.0k
Sara Musetti United States 12 821 1.3× 547 1.2× 599 1.6× 526 1.5× 396 1.5× 15 1.6k
Jiayan Wu China 20 698 1.1× 313 0.7× 563 1.5× 298 0.9× 181 0.7× 33 1.3k
Kuo‐Ching Mei United States 18 490 0.8× 281 0.6× 438 1.1× 331 1.0× 171 0.7× 32 1.1k

Countries citing papers authored by Xinghui Si

Since Specialization
Citations

This map shows the geographic impact of Xinghui Si's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinghui Si with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinghui Si more than expected).

Fields of papers citing papers by Xinghui Si

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinghui Si. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinghui Si. The network helps show where Xinghui Si may publish in the future.

Co-authorship network of co-authors of Xinghui Si

This figure shows the co-authorship network connecting the top 25 collaborators of Xinghui Si. A scholar is included among the top collaborators of Xinghui Si based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinghui Si. Xinghui Si is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gao, Yuxi, Sheng Ma, Xinghui Si, et al.. (2025). Hyaluronidase nanogel-armed CAR-T cell for synergistically reducing tumor extracellular matrix and improving efficacy against solid tumors. Nano Research. 18(5). 94907359–94907359. 1 indexed citations
3.
Ji, Guofeng, et al.. (2024). Targeting bacterial metabolites in tumor for cancer therapy: An alternative approach for targeting tumor-associated bacteria. Advanced Drug Delivery Reviews. 211. 115345–115345. 10 indexed citations
4.
Yao, Haochen, Juanjuan Huang, Xinghui Si, et al.. (2024). Trojan‐Horse Strategy Targeting the Gut‐Liver Axis Modulates Gut Microbiome and Reshapes Microenvironment for Orthotopic Hepatocellular Carcinoma Therapy. Advanced Science. 11(44). e2310002–e2310002. 9 indexed citations
5.
Si, Xinghui, Guofeng Ji, Sheng Ma, et al.. (2024). Minimally Invasive Injectable Gel for Local Immunotherapy of Liver and Gastric Cancer. Advanced Science. 11(38). e2405935–e2405935. 6 indexed citations
6.
Wang, Zhanfeng, et al.. (2024). Biopolymer immune implants co-loaded with TMZ, R848 and IOX1 for perioperative therapy of glioblastoma. Acta Biomaterialia. 189. 143–154. 2 indexed citations
7.
Shi, Zhiyuan, Xinyu Zhuang, Xinghui Si, et al.. (2024). Dynamic Covalent Hydrogel as a Single‐Dose Vaccine Adjuvant for Sustained Antigen Release and Significantly Elevated Humoral Immunity. Advanced Healthcare Materials. 13(23). e2400886–e2400886. 5 indexed citations
8.
Si, Xinghui, Sheng Ma, Zichao Huang, et al.. (2024). Injectable Nano-in-Gel Vaccine for Spatial and Temporal Control of Vaccine Kinetics and Breast Cancer Postsurgical Therapy. ACS Nano. 18(4). 3087–3100. 25 indexed citations
9.
Si, Xinghui, Guofeng Ji, Sheng Ma, et al.. (2024). Safety evaluation of biopolymer immune implants in rats and rabbits as well as therapeutic effects on gastric cancer peritoneal metastasis carcinoma. Science China Materials. 67(7). 2080–2089. 4 indexed citations
10.
Ma, Sheng, Haochen Yao, Xinghui Si, et al.. (2024). Orally available dextran-aspirin nanomedicine modulates gut inflammation and microbiota homeostasis for primary colorectal cancer therapy. Journal of Controlled Release. 370. 528–542. 21 indexed citations
11.
Wang, Qian, Yutao Cui, Xinghui Si, et al.. (2024). Vancomycin-Loaded in situ Gelled Hydrogel as an Antibacterial System for Enhancing Repair of Infected Bone Defects. International Journal of Nanomedicine. Volume 19. 10227–10245. 10 indexed citations
12.
Huang, Zichao, Xinyu Zhuang, Jiayu Zhao, et al.. (2023). Modularized viromimetic polymer nanoparticle vaccines (VPNVaxs) to elicit durable and effective humoral immune responses. National Science Review. 11(3). nwad310–nwad310. 19 indexed citations
13.
Si, Xinghui, Guofeng Ji, Sheng Ma, et al.. (2022). Comprehensive evaluation of biopolymer immune implants for peritoneal metastasis carcinoma therapy. Journal of Controlled Release. 353. 289–302. 18 indexed citations
14.
Xu, Yudi, Sheng Ma, Jiayu Zhao, et al.. (2022). Mannan-decorated pathogen-like polymeric nanoparticles as nanovaccine carriers for eliciting superior anticancer immunity. Biomaterials. 284. 121489–121489. 63 indexed citations
15.
Yu, Zhentao, Yudi Xu, Haochen Yao, et al.. (2021). A simple and general strategy for postsurgical personalized cancer vaccine therapy based on an injectable dynamic covalent hydrogel. Biomaterials Science. 9(20). 6879–6888. 19 indexed citations
16.
Xu, Yudi, Sheng Ma, Jiayu Zhao, et al.. (2021). Trinity immune enhancing nanoparticles for boosting antitumor immune responses of immunogenic chemotherapy. Nano Research. 15(2). 1183–1192. 11 indexed citations
17.
Si, Xinghui, Wantong Song, Shengcai Yang, et al.. (2020). Glucose and pH Dual‐Responsive Nanogels for Efficient Protein Delivery. Macromolecular Bioscience. 20(9). 1 indexed citations
18.
Si, Xinghui, Sheng Ma, Yudi Xu, et al.. (2020). Hypoxia-sensitive supramolecular nanogels for the cytosolic delivery of ribonuclease A as a breast cancer therapeutic. Journal of Controlled Release. 320. 83–95. 64 indexed citations
19.
Zhao, Jiayu, Sheng Ma, Yudi Xu, et al.. (2020). In situ activation of STING pathway with polymeric SN38 for cancer chemoimmunotherapy. Biomaterials. 268. 120542–120542. 84 indexed citations
20.
Si, Xinghui, Guofeng Ji, Sheng Ma, et al.. (2020). Biodegradable Implants Combined with Immunogenic Chemotherapy and Immune Checkpoint Therapy for Peritoneal Metastatic Carcinoma Postoperative Treatment. ACS Biomaterials Science & Engineering. 6(9). 5281–5289. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yudi Xu Breakdown of academic impact, for papers by Jinxing Xia Breakdown of academic impact, for papers by Suxin Li Breakdown of academic impact, for papers by Cao Dai Phung Breakdown of academic impact, for papers by Kyle C. Roche Breakdown of academic impact, for papers by Qingle Song Breakdown of academic impact, for papers by Edikan Archibong Breakdown of academic impact, for papers by Sara Musetti Breakdown of academic impact, for papers by Jiayan Wu Breakdown of academic impact, for papers by Kuo‐Ching Mei
Rankless by CCL
2026